Related Experiment Video
Updated: May 18, 2026
11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
In vitro salicylate does not further impair aging-induced brain mitochondrial dysfunction
I Marques-Aleixo1, S Rocha-Rodrigues, E Santos-Alves
1CIAFEL - Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto, Portugal. inesmaleixo@hotmail.com
Toxicology
|September 13, 2012
Summary
Aging and salicylate individually impair brain mitochondrial function. However, their combined effect does not appear to worsen mitochondrial endpoints, suggesting aging and this anti-inflammatory drug have separate impacts on brain energy production.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Pharmacology
Background:
- Aging and drug side effects can degrade brain mitochondrial bioenergetics.
- It is hypothesized that combined aging and drug exposure accelerate mitochondrial damage.
Purpose of the Study:
- To investigate the isolated and combined effects of aging and salicylate on rat brain mitochondrial function.
- To assess how aging and salicylate impact mitochondrial respiration, membrane potential, oxidative stress, and apoptosis markers.
Main Methods:
- Isolated brain mitochondria from adult and aged rats were analyzed.
- In vitro assays measured oxygen consumption, transmembrane electric potential (ΔΨ), and calcium-induced permeability transition pore (MPTP).
- Oxidative stress markers (aconitase, Mn-SOD, SH, MDA) and apoptotic proteins (Bax, Bcl-2) were quantified.
Main Results:
- Aging alone impaired mitochondrial respiration, ΔΨ, ADP phosphorylation, and MPTP susceptibility.
- Aged rats showed decreased malondialdehyde and increased Mn-SOD activity, with reduced Bcl-2 and increased Bax/Bcl-2 ratio.
- Salicylate increased lipid peroxidation and altered respiration in aged rats, but combined effects with aging were not synergistic.
Conclusions:
- Both aging and salicylate independently impair brain mitochondrial bioenergetics.
- The combination of aging and salicylate does not exacerbate mitochondrial dysfunction beyond their individual effects.
- Further research is needed to understand the specific mechanisms of aging and salicylate on brain mitochondria.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:37Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...